Activation of the damage-associated molecular pattern receptor P2X7 induces interleukin-1β release from canine monocytes

Veterinary Immunology and Immunopathology

Volumn 149, Issue 1-2, 2012, Pages 86-91

  Jalilian, Iman ^a,b,e   Peranec, Michelle ^a,b   Curtis, Belinda L ^c   Seavers, Aine ^d   Spildrejorde, Mari ^a,b   Sluyter, Vanessa ^a,b   Sluyter, Ronald ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b ILLAWARRA HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^c Albion Park Veterinary Hospital   (Australia)

^d Oak Flats Veterinary Clinic   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Damage associated molecular pattern receptor; Dog; Inflammasome; Interleukin 1 ; Monocyte; Purinergic receptor

Indexed keywords

A 438079; ADENOSINE TRIPHOSPHATE; CATION; CATION CHANNEL; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DOG; FLOW CYTOMETRY; IMMUNOBLOTTING; MONOCYTE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZOXAZOLES; CELL LINE; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; INFLAMMASOMES; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; MICE; MONOCYTES; PYRIDINES; QUINOLINIUM COMPOUNDS; RECEPTORS, PURINERGIC P2X7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TETRAZOLES;

CANIS FAMILIARIS;

EID: 84865544686     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.05.004     Document Type: Article

References (29)

1. 7 receptor. Bioorg. Med. Chem. Lett. 2010, 20:6370-6374.
2. Arulkumaran N., Unwin R.J., Tam F.W. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin. Investig. Drugs 2011, 20:897-915.
3. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., Hornung V., Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
4. Bours M.J., Dagnelie P.C., Giuliani A.L., Wesselius A., Di Virgilio F. P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front. Biosci. (Schol. Ed.) 2011, 3:1443-1456.
5. Bradley H.J., Browne L.E., Yang W., Jiang L.H. Pharmacological properties of the rhesus macaque monkey P2X7 receptor. Br. J. Pharmacol. 2011, 164:743-754.
6. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
7. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., Egerton J., Murfin M., Richardson J., Peck W.L., Grahames C.B., Casula M.A., Yiangou Y., Birch R., Anand P., Buell G.N. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114:386-396.
8. Constantinescu P., Wang B., Kovacevic K., Jalilian I., Bosman G.J., Wiley J.S., Sluyter R. P2X7 receptor activation induces cell death and microparticle release in murine erythroleukemia cells. Biochim. Biophys. Acta 2010, 1798:1797-1804.
9. Coutinho-Silva R., Ojcius D.M., Górecki D.C., Persechini P.M., Bisaggio R.C., Mendes A.N., Marks J., Burnstock G., Dunn P.M. Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages. Biochem. Pharmacol. 2005, 69:641-655.
10. 7 and the inflammasome. Trends Pharmacol. Sci. 2007, 28:465-472.
11. Donnelly-Roberts D.L., Jarvis M.F. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br. J. Pharmacol. 2007, 151:571-579.
12. Donnelly-Roberts D.L., Namovic M.T., Han P., Jarvis M.F. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br. J. Pharmacol. 2009, 157:1203-1214.
13. Duplantier A.J., Dombroski M.A., Subramanyam C., Beaulieu A.M., Chang S.P., Gabel C.A., Jordan C., Kalgutkar A.S., Kraus K.G., Labasi J.M., Mussari C., Perregaux D.G., Shepard R., Taylor T.J., Trevena K.A., Whitney-Pickett C., Yoon K. Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535. Bioorg. Med. Chem. Lett. 2011, 21:3708-3711.
14. Gadeock S., Tran J.N., Georgiou J.G., Jalilian I., Taylor R.M., Wiley J.S., Sluyter R. TGF-β1 prevents up-regulation of the P2X7 receptor by IFN-γ and LPS in leukemic THP-1 monocytes. Biochim. Biophys. Acta 2010, 1798:2058-2066.
15. 7 receptors. Am. J. Physiol. Cell Physiol. 2000, 279:C1189-C1197.
16. Hughes J.P., Hatcher J.P., Chessell I.P. The role of P2X7 in pain and inflammation. Purinergic Signal. 2007, 3:163-169.
17. Jarvis M.F., Khakh B.S. ATP-gated P2X cation channels. Neuropharmacology 2009, 56:208-215.
18. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
19. Labasi J.M., Petrushova N., Donovan C., McCurdy S., Lira P., Payette M.M., Brissette W., Wicks J.R., Audoly L., Gabel C.A. Absence of the P2X7 receptor alters leukcoyte function and attenuates an inflammatory response. J. Immunol. 2002, 168:6436-6445.
20. Maccoux L.J., Salway F., Day P.J.R., Clements D.N. Expression profiling of select cytokines in canine osteoarthritis tissues. Vet. Immunol. Immunopathol. 2007, 118:59-67.
21. Mehta V.B., Hart J., Wewers M.D. ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 2001, 276:3820-3826.
22. Perregaux D.G., McNiff P., Laliberte R., Conklyn M., Gabel C.A. ATP acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood. J. Immunol. 2000, 165:4615-4623.
23. Roman S., Cusdin F.S., Fonfria E., Goodwin J.A., Reeves J., Lappin S.C., Chambers L., Walter D.S., Clay W.C., Michel A.D. Cloning and pharmacological characterization of the dog P2X7 receptor. Br. J. Pharmacol. 2009, 158:1513-1526.
24. 7 receptor by a novel protein tyrosine kinase antagonist. Biochem. Biophys. Res. Commun. 2008, 365:515-520.
25. 7 receptor impairs ATP-induced IL-1β release from human monocytes. J. Immunol. 2004, 172:3399-3405.
26. 7 receptor: greatly increased function compared to human erythrocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R2090-R2098.
27. Sluyter R., Stokes L. Significance of P2X7 receptor variants to human health and disease. Recent Pat. DNA Gene Seq. 2011, 5:41-54.
28. Stevenson R.O., Taylor R.M., Wiley J.S., Sluyter R. The P2X7 receptor mediates the uptake of organic cations in canine erythrocytes and mononuclear leukocytes: comparison to equivalent human cell types. Purinergic Signal. 2009, 5:385-394.
29. Wiley J.S., Sluyter R., Gu B.J., Stokes L., Fuller S.J. The human P2X7 receptor and its role in innate immunity. Tissue Antigens 2011, 78:321-332.